Pharmaceutical Technology - May 2021

Pharmaceutical Technology - Biologics and Sterile Drug Manufacturing - May 2021

Issue link: https://www.e-digitaleditions.com/i/1373953

Contents of this Issue

Navigation

Page 9 of 63

Specialized areas of focus: • Cytotoxics • Highly Potent Compounds • Antibody-Drug Conjugates (ADCs) • Biologics • Lyophilized Products Capabilities: • Lyophilization • Aseptic Powder Filling • Aseptic Liquid Filling • Sterile Crystallization • Liposomes/Emulsions Baxter is a registered trademark of Baxter International Inc. 920810-01 Visit our website at: baxterbiopharmasolutions.com A World-Class Manufacturer of Oncology Products and Other Highly Sophisticated Compounds Offering longevity of experience in handling complex sterile manufacturing challenges. Baxter's facility in Halle/Westfalen, Germany, is dedicated to oncology products and is SafeBridge certified. Uniquely designed to deliver high-quality products with optimum efficiency and speed-to-market, we provide integrated technologies and services for clinical to commercial production. With over 60 years of experience, we are focused on excellence in oncology manufacturing.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2021 - Pharmaceutical Technology - Biologics and Sterile Drug Manufacturing - May 2021